138 related articles for article (PubMed ID: 12182916)
1. Separation of active and inactive forms of human antithrombin by heparin affinity chromatography.
Heger A; Grunert T; Schulz P; Josic D; Buchacher A
Thromb Res; 2002 Apr; 106(2):157-64. PubMed ID: 12182916
[TBL] [Abstract][Full Text] [Related]
2. Commercial antithrombin concentrate contains inactive L-forms of antithrombin.
Chang WS; Harper PL
Thromb Haemost; 1997 Feb; 77(2):323-8. PubMed ID: 9157590
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
Lane DA; Flynn A; Ireland H; Erdjument H; Samson D; Howarth D; Thompson E
Br J Haematol; 1987 Apr; 65(4):451-6. PubMed ID: 3580302
[TBL] [Abstract][Full Text] [Related]
4. Pasteurisation induced changes in an antithrombin III concentrate.
Winkelman L; Haddon ME
Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862
[TBL] [Abstract][Full Text] [Related]
5. Studies of the heterogeneity of antithrombin III concentrates.
Barrowcliffe TW; Eggleton CA; Mahmoud M
Br J Haematol; 1983 Sep; 55(1):37-46. PubMed ID: 6882687
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.
Collen D; Schetz J; de Cock F; Holmer E; Verstraete M
Eur J Clin Invest; 1977 Feb; 7(1):27-35. PubMed ID: 65284
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
8. A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity.
Larsson H; Akerud P; Nordling K; Raub-Segall E; Claesson-Welsh L; Björk I
J Biol Chem; 2001 Apr; 276(15):11996-2002. PubMed ID: 11278631
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding.
Peterson CB; Blackburn MN
J Biol Chem; 1985 Jan; 260(1):610-5. PubMed ID: 3965464
[TBL] [Abstract][Full Text] [Related]
10. Behavior of antithrombin III isoforms on immobilized heparins. Evidence that the isoforms bind to different numbers of low-affinity heparin sites.
Carlson TH; Babcock T; Atencio AC; Levinson C; Mora HR
J Biol Chem; 1988 Feb; 263(5):2187-94. PubMed ID: 3339006
[TBL] [Abstract][Full Text] [Related]
11. Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.
Finazzi G; Tran TH; Barbui T; Duckert F
Br J Haematol; 1985 Feb; 59(2):259-63. PubMed ID: 3970857
[TBL] [Abstract][Full Text] [Related]
12. Further characterization of a pathological isoantithrombin with no affinity for heparin (antithrombin III Roma).
De Stefano V; Leone G; Ferrelli R; Di Donfrancesco A; De Martini D; Bizzi B
Thromb Res; 1987 Oct; 48(1):23-30. PubMed ID: 3424283
[TBL] [Abstract][Full Text] [Related]
13. Isolation and partial characterization of two distinct types of antithrombin III from rabbit.
Carlson TH; Atencio AC
Thromb Res; 1982 Jul; 27(1):23-34. PubMed ID: 7123512
[TBL] [Abstract][Full Text] [Related]
14. [Heterogeneity of mammalian antithrombin III].
Bashkov GV; Kalishevskaia TM; Strukova SM
Biokhimiia; 1989 Nov; 54(11):1797-803. PubMed ID: 2627551
[TBL] [Abstract][Full Text] [Related]
15. A capillary zone electrophoresis method to detect conformers and dimers of antithrombin in therapeutic preparations.
Marie AL; Tran NT; Saller F; Abdou YM; Zeau P; Plantier JL; Urbain R; Borgel D; Taverna M
Electrophoresis; 2016 Jul; 37(12):1696-703. PubMed ID: 26989842
[TBL] [Abstract][Full Text] [Related]
16. Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'.
Sørensen PJ; Sas G; Petó I; Blaskó G; Kremmer T; Samu A
Thromb Res; 1982 May; 26(3):211-9. PubMed ID: 7112514
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin.
Kress LF; Catanese J
Biochim Biophys Acta; 1980 Sep; 615(1):178-86. PubMed ID: 7426659
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.
Wolf M; Boyer C; Tripodi A; Meyer D; Larrieu MJ; Mannucci PM
Blood; 1985 Feb; 65(2):496-500. PubMed ID: 3967090
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
Horner AA
Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
[TBL] [Abstract][Full Text] [Related]
20. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
Takahashi HK; Nader HB; Dietrich CP
Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
